Pharmacokinetics and blood-brain barrier transport of an anti- transferrin receptor monoclonal antibody (OX26) in rats after chronic treatment with the antibody

Drug Metabolism and Disposition

Volumn 26, Issue 9, 1998, Pages 937-939

  Wu, Dafang ^b   Pardridge, William M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; IMMUNOGLOBULIN G2A; MONOCLONAL ANTIBODY; TRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; TISSUE CULTURE;

ANIMALS; ANTIBODIES, MONOCLONAL; AREA UNDER CURVE; BLOOD-BRAIN BARRIER; INJECTIONS, INTRAVENOUS; MALE; MICE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFERRIN;

EID: 0344352501     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Descamps L, Dehouck M-P, Torpier G and Cecchelli R (1996) Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. Am J Physiol 270:H1149-H1158.
2. Kang Y-S, Bickel U and Pardridge WM (1994) Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptor. Drug Metab Dispos 22:99-105.
3. Kang Y-S and Pardridge WM (1994) Use of neutral-avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate. J Pharmacol Exp Ther 269:344-350.
4. Keyna U, Platzer E, Woith W, Nusslein I, Kalden JR and Manger B (1994) Differential effects of transferrin receptor antibodies on growth and receptor expression of human lymphocytic and myelocytic cell lines. Eur J Haematol 52:169-175.
5. Lesley J and Schulte RJ (1985) Inhibition of cell growth by monoclonal anti-transferrin receptor antibodies. Mol Cell Biol 5:1814-1821.
6. Lu J, Kaur C and Ling E-A (1995) Expression and upregulation of transferrin receptors and iron uptake in the epiplexus cells of different aged rats injected with lipopolysaccharide and interferon-gamma. J Anat 187:603-611.
7. National Institutes of Health (1985) Principles of Laboratory Animal Care, National Institutes of Health Publication 85-23. National Institutes of Health, Bethesda, MD.
8. Pardridge WM (1997) Drug delivery to the brain. J Cereb Blood Flow Metab 17:713-731.
9. Pardridge WM, Buciak JL and Friden PM (1991) Selective transport of anti-transferrin receptor antibody through the blood-brain barrier in vivo. J Pharmacol Exp Ther 259:66-70.
10. Pardridge WM, Eisenberg J and Yang J (1987) Human blood-brain barrier transferrin receptor. Metabolism 36:892-895.
11. Rudolph JR, Regoeczi E and Southward S (1988) Quantification of rat hepatocyte transferrin receptors with poly-and monoclonal antibodies and protein A. Histochemistry 88:187-192.
12. White S, Taetle R, Seligman PA, Rutherford M and Trowbridge IS (1990) Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. Cancer Res 50:6295-6301.